Kalayoglu Murat
Insider CIK 2000002 · RNAC Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2026-04-02 | 2026-04-06 | 22,740 | — | $0 | 33,662 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2026-04-02 | 2026-04-06 | 758,001 | — | $0 | 5,313,261 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2026-01-02 | 2026-01-06 | 7,800 | — | $0 | 7,800 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2026-01-02 | 2026-01-06 | 2,600 | — | $0 | 511,577 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2025-01-02 | 2025-01-06 | 7,800 | — | $0 | 7,800 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2025-01-02 | 2025-01-06 | 2,600 | — | $0 | 508,977 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-10-11 | 2024-10-15 | 45,551 | — | $0 | 56,402 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-10-11 | 2024-10-15 | 1,518,373 | — | $0 | 4,555,260 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 87,803 | — | $0 | 101,953 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 14,756 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-04-08 | 2024-04-10 | 2,926,764 | — | $0 | 3,036,887 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-04-08 | 2024-04-10 | 491,853 | — | $0 | 506,377 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2024-01-02 | 2024-01-04 | 228,000 | — | $0 | 228,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2024-01-02 | 2024-01-04 | 178,000 | — | $0 | 435,739 | SEC↗ |
| RNAC Cartesian Therapeutics, In | J Other deriv | 2023-11-13 | 2023-11-15 | 189,137 | — | $0 | 189,137 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2023-11-13 | 2023-11-15 | 14,756 | — | $0 | 14,756 | SEC↗ |
| RNAC Cartesian Therapeutics, In | P Buy deriv | 2023-11-13 | 2023-11-15 | 620 | $249999.98 | $154.91M | 620 | SEC↗ |
| RNAC Cartesian Therapeutics, In | J Other | 2023-11-13 | 2023-11-15 | 3,303,699 | — | $0 | 3,303,699 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2023-11-13 | 2023-11-15 | 257,739 | — | $0 | 257,739 | SEC↗ |